BURST is an innovative incubation program for high-potential medical technology startups and scale-ups that will position London as a focal point for life science innovation. The program will provide intensive support to 30 companies, including approximately $3 million in cash and in-kind support.
Each of BURST’s three cohorts will include ten companies, primarily from the life science, medical device and health information technology fields. Each 12-month cohort will focus on four main pillars: market validation, company structure, IP, and investor readiness.
April 1, 2017 – March 31, 2018
Application deadline: March 7, 2017
August 1, 2017 – July 31, 2018
Application deadline: July 1, 2017
December 1, 2017 – November 30, 2018
Application deadline: November 1, 2017
Each participating company will receive $30,000 in funding, plus $10,000 for professional development provided by TechAlliance. Approved life science companies will also receive $30,000 from the London Medical Network, for a total of $70,000.
To qualify for London Medical Network funding, BURST participants will be obligated to maintain a presence in London for a minimum of 24 months after the conclusion of their cohort.
Applications for Cohort #2 will open June 1. Please sign up below for updates.
BURST By the Numbers
Approximate value of total cash and in-kind investment through BURST
Participating companies over three cohorts
BURST cash investment available to qualifying companies, plus significant in-kind support
BURST Program Structure
Prospective companies will complete an online application form outlining their technologies and proposed use of funds that will be reviewed and accepted by a panel of experts.
Space & Programming
Each company will be provided shared workshop and a common area for programming and cohort-specific learning activities.
Each company will work closely with experts in market research, corporate structure and IP to determine gaps in their company or technology.
Each company will work with a mentor to finalzie their plans, then meet on a bi-weekly basis to monitor progress and receive guidance.
Each cohort will conclude with a Demo Day, showcasing their technologies to investors and industry representatives.